Freezedrying type vaccine of AIDS recombined poxvirus with Ankara gene stock carrier, and preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JILIN UNIV
- Publication Date
- 2005-11-16
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biological products, and in particular relates to the preparation of a freeze-dried formulation vaccine using recombinant MVA virus as an expression vector. Background technique
[0002] AIDS (HIV) is considered to be the first major infectious disease that directly threatens human health in the world. More than 95% of HIV infections occur in developing countries. So far, education and interventions in high-risk behaviors have only slowed the spread, not stopped it. High-efficiency antiviral therapy is expensive and too complicated for most infected people, and in addition, it cannot completely eliminate the virus from the body. In this case, only the AIDS vaccine can really effectively prevent and control AIDS. In particular, it is necessary to receive safe, highly immunogenic, and highly effective AIDS vaccines.
[0003] In recent years, the study of live vector vaccines has received more and more a...